Major Lp(a)-Lowering Drug Fails To Prevent Heart Attacks In Big Trial
5h
1
Researchers reported Saturday that the experimental drug pelacarsen, once seen as a potential game-changer for heart disease, failed to prevent heart attacks, strokes or other major cardiovascular events in a large international trial unveiled at the American Heart Association meeting in Chicago. NPR
